Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 3978 (MIR3978), also known as hsa-mir-3978, is a predicted member of the microRNA family in humans. MicroRNAs are small (~22 nucleotide), endogenous, non-coding RNAs that regulate gene expression by binding to complementary sequences in target messenger RNAs (mRNAs), leading to mRNA degradation or translational inhibition[5][3][6][1]. While microRNAs as a class play crucial roles in numerous biological pathways and diseases[1][6][5], MIR3978 itself does not appear in peer-reviewed studies on biological function, disease roles, or therapeutic targeting, nor is it listed as a biomarker or drug target in major resources. The available information is limited to primary, computational prediction and nomenclature, with no experimental validation or clinical relevance currently documented.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 3978 (MIR3978).